PENTARAY NAV HIGH-DENSITY MAPPING ECO CATHETER UNK_PENTARAY

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative report with the FDA on 2020-01-23 for PENTARAY NAV HIGH-DENSITY MAPPING ECO CATHETER UNK_PENTARAY manufactured by Biosense Webster Inc..

Event Text Entries

[176223019] If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda. Manufacturer? S ref # (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[176223020] It was reported that a (b)(6)-year-old male patient ((b)(6) lbs) with substantial history including myocardial infarction, recent placement of stents, a bypass, low ejection fraction (15-20%) and numerous shocks from his defibrillator the previous two weeks due to episodes of ventricular tachycardia (vt), underwent an ischemic ventricular tachycardia (isvt) ablation procedure with a pentaray nav high-density mapping eco catheter and suffered cardiac arrest (requiring shocks and chest compressions) and death. The patient had a history of ischemic ventricular tachycardia with a low ejection fraction between 15-20% and history of ventricular tachycardia storm. Patient condition was very poor according to the physician and he expressed that this was a dire situation and a final attempt for survivability. Although there was a clear electrocardiogram during the case, patient began to have a decline in pulse and eventually loss in blood pressure suggesting pulseless electrical activity. Transseptal had been completed but there was no effusion by intracardiac echocardiography (ice). Voltage map had been started at that time. There was no evidence for product malfunction during the case and no errors were reported. Ice was utilized during the case and carto sound provided ultrasound imaging appropriately during resuscitation efforts. Despite resuscitative efforts, patient expired. Following the transseptal puncture, while voltage mapping was being applied in the left ventricle with a pentaray catheter, the nurse anesthetists noticed a drop-in the patient? S blood pressure followed by a loss of pulse. On the intracardiac echocardiography (ice), it was clear the heart was not adequately pumping blood. The medical intervention provided was shocks and compression, but nothing was successfully able to bring a pulse back and the patient expired. No bwi product malfunctions were reported. No effusion occurred during the case. No rf energy had been delivered. Physician? S opinion regarding the cause of the adverse event is that it was related to the patient? S prior condition.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2029046-2020-00141
MDR Report Key9624936
Report SourceCOMPANY REPRESENTATIVE
Date Received2020-01-23
Date of Report2019-12-30
Date of Event2019-12-30
Date Mfgr Received2020-02-05
Date Added to Maude2020-01-23
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. GABRIEL ALFAGEME
Manufacturer Street31 TECHNOLOGY DRIVE
Manufacturer CityIRVINE CA 92618
Manufacturer CountryUS
Manufacturer Postal92618
Manufacturer Phone949789-868
Manufacturer G1BIOSENSE WEBSTER INC (JUAREZ)
Manufacturer StreetCIRCUITO INTERIOR NORTE 1820PARQUE INDUSTRIAL SALVACAR
Manufacturer CityJUAREZ 32599
Manufacturer CountryMX
Manufacturer Postal Code32599
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NamePENTARAY NAV HIGH-DENSITY MAPPING ECO CATHETER
Generic NameCATHETER, INTRACARDIAC MAPPING, HIGH-DENSITY ARRAY
Product CodeMTD
Date Received2020-01-23
Catalog NumberUNK_PENTARAY
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerBIOSENSE WEBSTER INC.
Manufacturer Address33 TECHNOLOGY DRIVE IRVINE CA 92618 US 92618


Patients

Patient NumberTreatmentOutcomeDate
101. Death; 2. Required No Informationntervention 2020-01-23

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.